Steris | STE - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
3M USD 1.06B 317M 2026-06
Accuray USD 124.78M 2.54M 2025-12
Baxter International USD 735M 7M 2026-06
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Boston Scientific USD 1.8B 22M 2026-06
CONMED USD 145.55M 3.85M 2026-06
Cooper Companies USD 401.3M 274.9M 2026-06
Dexcom USD 358.7M 9M 2026-06
Ecolab USD 1.14B 39.2M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Fortive USD 417.9M 600K 2026-06
Getinge SEK 2.65B 452M 2024-12
Globus Medical USD 286.82M 10.95M 2026-06
Haemonetics USD 118.94M 1.99M 2026-06
Idexx Laboratories USD 288.09M 11.76M 2026-06
Inogen USD 43.77M 510K 2024-06
Insulet USD 344.8M 27.6M 2026-06
Integra LifeSciences USD 166.22M 12.01M 2026-06
Intuitive Surgical USD 617.9M 4.6M 2026-06
J&J USD 6.25B 168M 2026-09
Olympus JPY 125.03B 14.31B 2026-06
Orthofix International USD 130.35M 11.31M 2025-12
Owens Minor USD 258.98M 7.5M 2025-12
ResMed USD 290.65M 10.86M 2026-06
Steris USD 369.7M 17.9M 2026-06
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 111.64M 3.45M 2026-06
Teleflex USD 213.52M 12.5M 2026-06
Thermo Fisher Scientific USD 1.91B 111M 2026-06
Zimmer Biomet Holdings USD 911.6M 61.7M 2026-06